• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom.从英国普通公众中获得的特定肝性脑病健康状况的效用值。
Health Qual Life Outcomes. 2014 Jun 10;12:89. doi: 10.1186/1477-7525-12-89.
2
Utility values for specific chronic myeloid leukemia chronic phase health states from the general public in the United Kingdom.英国普通公众对特定慢性髓性白血病慢性期健康状态的效用值。
Leuk Lymphoma. 2014 Aug;55(8):1870-5. doi: 10.3109/10428194.2013.854886. Epub 2014 Jan 24.
3
Interpretation of health and vision utilities in low vision patients.低视力患者健康与视觉效用的解读
Optom Vis Sci. 2012 Mar;89(3):288-95. doi: 10.1097/OPX.0b013e318241720f.
4
Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.使用时间权衡和标准赌博效用在脊髓损伤个体中的假设检验。
Arch Phys Med Rehabil. 2012 Feb;93(2):245-52. doi: 10.1016/j.apmr.2011.08.039.
5
The utility assessment method order influences measurement of parents' risk attitude.效用评估方法的顺序会影响父母风险态度的测量。
Value Health. 2012 Sep-Oct;15(6):926-32. doi: 10.1016/j.jval.2012.04.008. Epub 2012 Jun 26.
6
Health-related quality of life in patients with uveitis.葡萄膜炎患者的健康相关生活质量。
Br J Ophthalmol. 2019 Sep;103(9):1284-1288. doi: 10.1136/bjophthalmol-2018-312882. Epub 2018 Oct 25.
7
What utility scores do mental health service users, healthcare professionals and members of the general public attribute to different health states? A co-produced mixed methods online survey.心理健康服务使用者、医疗保健专业人员和普通公众对不同健康状况赋予了哪些效用评分?一项共同制定的混合方法在线调查。
PLoS One. 2018 Oct 23;13(10):e0205223. doi: 10.1371/journal.pone.0205223. eCollection 2018.
8
The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation.时间跨度很重要:一项探索性研究的结果,该研究在时间权衡和标准博弈效用诱导中改变了时间框架。
Eur J Health Econ. 2016 Nov;17(8):979-990. doi: 10.1007/s10198-015-0740-7. Epub 2015 Nov 26.
9
Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population.在韩国人群中,标准博弈法与评分量表及时间权衡技术相比的可行性、可比性和可靠性。
Qual Life Res. 2017 Dec;26(12):3387-3397. doi: 10.1007/s11136-017-1676-4. Epub 2017 Aug 11.
10
Health state utilities for metastatic breast cancer in Taiwan.台湾转移性乳腺癌的健康状态效用。
Breast. 2020 Jun;51:57-64. doi: 10.1016/j.breast.2020.03.001. Epub 2020 Mar 6.

引用本文的文献

1
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.接受冠状动脉介入治疗后接受双联抗血小板治疗和三联治疗的患者的出血风险:ADAPTT 回顾性基于人群的队列研究。
Health Technol Assess. 2023 May;27(8):1-257. doi: 10.3310/MNJY9014.
2
Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy.利福昔明治疗肝性脑病患者的成本效益分析。
J Manag Care Spec Pharm. 2020 Jun;26(6):750-757. doi: 10.18553/jmcp.2020.26.6.750.
3
Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study.双联抗血小板治疗期间轻、重度出血事件对健康相关生活质量的影响:系统文献回顾和患者偏好研究。
Health Qual Life Outcomes. 2018 Sep 20;16(1):191. doi: 10.1186/s12955-018-1019-3.
4
Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.肿瘤学中特定疾病或通用的基于偏好的测量方法?欧洲癌症研究与治疗组织8维度健康状况量表(EORTC - 8D)与欧洲五维度健康量表3级版本(EQ - 5D - 3L)的比较
Qual Life Res. 2017 May;26(5):1163-1176. doi: 10.1007/s11136-016-1443-y. Epub 2016 Nov 9.
5
Can the general public use vignettes to discriminate between Alzheimer's disease health states?普通公众能否使用视觉模拟量表来区分阿尔茨海默病的健康状态?
BMC Geriatr. 2016 Feb 3;16:36. doi: 10.1186/s12877-016-0207-4.

本文引用的文献

1
Utility values for specific chronic myeloid leukemia chronic phase health states from the general public in the United Kingdom.英国普通公众对特定慢性髓性白血病慢性期健康状态的效用值。
Leuk Lymphoma. 2014 Aug;55(8):1870-5. doi: 10.3109/10428194.2013.854886. Epub 2014 Jan 24.
2
Utility values for advanced soft tissue sarcoma health States from the general public in the United kingdom.英国公众对晚期软组织肉瘤健康状态的效用值。
Sarcoma. 2013;2013:863056. doi: 10.1155/2013/863056. Epub 2013 Mar 17.
3
Health-State Utilities in Liver Cirrhosis: A Cross-sectional Study.肝硬化患者的健康状态效用:一项横断面研究。
Int J Prev Med. 2012 Mar;3(Suppl 1):S94-S101.
4
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.随机临床试验:利福昔明改善肝性脑病肝硬化患者的健康相关生活质量 - 一项双盲安慰剂对照研究。
Aliment Pharmacol Ther. 2011 Oct;34(8):853-61. doi: 10.1111/j.1365-2036.2011.04808.x. Epub 2011 Aug 17.
5
Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available.在缺乏特定疾病数据的情况下,使用来自一般人群的健康状态效用值来近似决策分析模型中的基线。
Value Health. 2011 Jun;14(4):539-45. doi: 10.1016/j.jval.2010.10.029. Epub 2011 Apr 22.
6
Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.综述文章:肝性脑病临床试验设计——国际肝性脑病和氮代谢学会(ISHEN)共识声明。
Aliment Pharmacol Ther. 2011 Apr;33(7):739-47. doi: 10.1111/j.1365-2036.2011.04590.x. Epub 2011 Feb 9.
7
Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.感染和全身炎症与 3/4 级肝性脑病相关,而不是氨,与肝硬化患者的死亡率无关。
J Hepatol. 2011 Apr;54(4):640-9. doi: 10.1016/j.jhep.2010.07.045. Epub 2010 Dec 1.
8
Rifaximin for the treatment of hepatic encephalopathy.利福昔明治疗肝性脑病。
Expert Rev Gastroenterol Hepatol. 2010 Dec;4(6):665-77. doi: 10.1586/egh.10.78.
9
Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study.轻微型肝性脑病呈波动性病程:一项为期三年的前瞻性队列随访研究结果。
Singapore Med J. 2009 Mar;50(3):255-60.
10
Health-state utilities in liver disease: a systematic review.肝病中的健康状态效用:一项系统评价。
Med Decis Making. 2008 Jul-Aug;28(4):582-92. doi: 10.1177/0272989X08315240. Epub 2008 Apr 18.

从英国普通公众中获得的特定肝性脑病健康状况的效用值。

Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom.

机构信息

Catalyst Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 1BN, UK.

出版信息

Health Qual Life Outcomes. 2014 Jun 10;12:89. doi: 10.1186/1477-7525-12-89.

DOI:10.1186/1477-7525-12-89
PMID:24917331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4070646/
Abstract

BACKGROUND AND AIMS

To elicit utility values for five health states corresponding to increasing severity of hepatic encephalopathy, from members of the general public in the UK. The health states studied were Conn grades 0, 1, 2, 3 and 4.

METHODS

Interviewer-administered time trade-off (TTO) and standard gamble (SG) utilities were elicited for the five health states from a random sample of 200 members of the general public in the UK, using health state descriptions validated by clinicians and members of the general public.

RESULTS

Respondents' mean age was 49.5 years and 49% were female. Mean utilities were 0.962 (TTO) and 0.915 (SG) for Conn grade 0; 0.912 (TTO) and 0.837 (SG) for Conn grade 1; 0.828 (TTO) and 0.683 (SG) for Conn grade 2; 0.691 (TTO) and 0.489 (SG) for Conn grade 3; and 0.429 (TTO) and 0.215 (SG) for Conn grade 4. The TTO and SG values between the five Conn grades were significantly different (p < 0.001). Additionally, the TTO value was significantly higher than the SG value for the corresponding state (p <0.0001).

CONCLUSION

These findings quantify how different Conn grades and level of response to treatment may impact on the health-related quality of life of patients with hepatic encephalopathy. There were greater preference values for lower levels of disease, with the highest value associated with Conn grade 0. These health state preference values can be used to estimate the outcomes of different interventions for hepatic encephalopathy in terms of quality-adjusted life years.

摘要

背景与目的

旨在从英国普通公众中获取对应于肝性脑病严重程度增加的五种健康状态的效用值。所研究的健康状态为 Conn 等级 0、1、2、3 和 4。

方法

使用经过临床医生和普通公众验证的健康状态描述,通过英国普通公众的随机样本 200 人,采用访谈者管理的时间权衡 (TTO) 和标准博弈 (SG) 效用,对五种健康状态进行评估。

结果

受访者的平均年龄为 49.5 岁,49%为女性。Conn 等级 0 的平均效用为 0.962(TTO)和 0.915(SG);Conn 等级 1 的平均效用为 0.912(TTO)和 0.837(SG);Conn 等级 2 的平均效用为 0.828(TTO)和 0.683(SG);Conn 等级 3 的平均效用为 0.691(TTO)和 0.489(SG);Conn 等级 4 的平均效用为 0.429(TTO)和 0.215(SG)。五个 Conn 等级之间的 TTO 和 SG 值差异具有统计学意义(p<0.001)。此外,相应状态的 TTO 值明显高于 SG 值(p<0.0001)。

结论

这些发现量化了不同 Conn 等级和治疗反应水平可能对肝性脑病患者的健康相关生活质量的影响。疾病程度越低,偏好值越高,Conn 等级 0 的偏好值最高。这些健康状态偏好值可用于根据质量调整生命年来估计肝性脑病不同干预措施的结果。